In addition, TNF-α increases circulating levels of leptin and resistin when interacting synergistically with IL-6, favoring increased peripheral insulin resistance [2, 32, 45–47] and greater chances of developing T2DM [22, 48]. The gene discussed is TNF; the disease is Insulin resistance.